| [1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
|
| [2] |
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604.
|
| [3] |
Feitelson MA. Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma[J]. J Hepatobiliary Pancreat Surg, 1998, 5(4):367-374.
|
| [4] |
Gerbes AL, Caselmann WH. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins[J]. J Hepatol, 1993, 19(2):312-315.
|
| [5] |
Meng X, Franklin DA, Dong J, et al. MDM2-p53 pathway in hepatocellular carcinoma[J]. Cancer Res, 2014, 74(24):7161-7167.
|
| [6] |
Murray RZ, Wylie FG, Khromykh T, et al. Syntaxin 6 and Vti1b form a novel SNARE complex, which is up-regulated in activated macrophages to facilitate exocytosis of tumor necrosis factor-α[J].J Biol Chem, 2005, 280(11):10478-10483.
|
| [7] |
Reverter M, Rentero C, Garcia-melero A, et al. Cholesterol regulates Syntaxin 6 trafficking at trans-Golgi network endosomal boundaries[J]. Cell Rep, 2014, 7(3):883-897.
|
| [8] |
Zhang Y, Shu L, Chen X. Syntaxin 6, a regulator of the protein trafficking machinery and a target of the p53 family, is required for cell adhesion and survival[J]. J Biol Chem, 2008, 283(45):30689-30698.
|
| [9] |
Du J, Liu X, Wu Y, et al. Essential role of STX6 in esophageal squamous cell carcinoma growth and migration[J]. Biochem Biophys Res Commun, 2016, 472(1):60-67.
|
| [10] |
Peak TC, Su Y, Chapple AG, et al. Syntaxin 6: a novel predictive and prognostic biomarker in papillary renal cell carcinoma[J]. Sci Rep, 2019, 9(1):3146.
|
| [11] |
Wu C, Orozco C, Boyer J, et al. BioGPS: an extensible and customizable portal for querying and organizing geneannotation resources[J]. Genome Biol, 2009, 10(11):R130.
|
| [12] |
Rhodes DR, Kalyana-sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles[J]. Neoplasia, 2007, 9(2):166-180.
|
| [13] |
Nagy á, Lánczky A, Menyhárt O, et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expressiondata of independent datasets[J]. Sci Rep, 2018, 8(1):9227.
|
| [14] |
Szklarczyk D, Franceschini A, Wyder S, et al. String v10: protein-protein interaction networks, integrated over the tree oflife[J]. Nucleic Acids Res, 2015, 43(Database issue):D447-452.
|
| [15] |
Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world[J]. World J Gastroenterol, 2017, 23(29):5282-5294.
|
| [16] |
Tang A, Hallouch O, Chernyak V, et al. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis[J]. Abdom Radiol, 2018, 43(1):13-25.
|
| [17] |
Du Y, Shen J, Hsu JL, et al. Syntaxin 6-mediated Golgi translocation plays an important role in nuclearfunctions of EGFR through microtubule-dependent trafficking[J]. Oncogene, 2014, 33(6):756-770.
|
| [18] |
Wendler F, Tooze S. Syntaxin 6: the promiscuous behaviour ofa SNARE protein.[J]. Traffic, 2001, 2(9):606-611.
|
| [19] |
Perera HK, Clarke M, Morris NJ, et al. Syntaxin 6 regulates Glut4 trafficking in 3T3-L1 adipocytes[J]. Mol Biol Cell, 2003, 14(7):2946-2958.
|
| [20] |
Kabayama H, Tokushige N, Takeuchi M, et al. Syntaxin 6 regulates nerve growth factor-dependent neurite outgrowth[J]. Neurosci Lett, 2008, 436(3):340-344.
|
| [21] |
Dingjan I, Linders PTA, Verboogen DRJ, et al. Endosomal and phagosomal SNAREs[J]. Physiol Rev, 2018, 98(3):1465-1492.
|